Cover Image
Market Research Report

Global qPCR Reagent Market 2017-2021

Published by TechNavio (Infiniti Research Ltd.) Product code 574584
Published Content info 91 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global qPCR Reagent Market 2017-2021
Published: October 26, 2017 Content info: 91 Pages
Description

About qPCR Reagent

Quantitative Polymerase Chain Reaction (qPCR) reagent is a solution or mixture that is used in qPCR technique to amplify and quantitate Deoxyribonucleic acid (DNA) sequences in a sample. It also called as Real-time Polymerase Chain Reaction reagent. Essentially, qPCR reagents are sold in the form of separate solutions in kits or as optimized master-mixes used specifically for a function. qPCR kits called as Core kits have solutions separately in tubes with a specific quantity while master-mixes have solutions that have been measured and mixed which perform the basic functions and are available in a single tube.

Technavio's analysts forecast the global qPCR reagent market to grow at a CAGR of 7.20% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global qPCR reagent market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global qPCR Reagent Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Agilent Technologies
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche
  • Thermo Fisher Scientific

Other Prominent Vendors

  • Cole-Parmer
  • Norgen Biotek
  • Promega
  • Qiagen
  • Sigma-Aldrich
  • TAKARA BIO

Market driver

  • Increasing demand for drug discovery and pharmacogenomics
  • For a full, detailed list, view our report

Market challenge

  • High setting-up and reagents refill costs
  • For a full, detailed list, view our report

Market trend

  • Increase in M&A and internal restructuring in life science industries
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents
Product Code: IRTNTR15282

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: INTRODUCTION

  • Market outline
  • Market size and forecast
  • Five forces analysis

PART 05: MARKET SEGMENTATION BY END-USERS

  • Market overview
  • Hospitals and diagnostic centers
  • Pharmaceutical and biotechnology companies
  • Others

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market overview
  • Global dye-based qPCR reagent market
  • Global probe-based qPCR reagent market

PART 07: GEOGRAPHICAL SEGMENTATION

  • Market segmentation by geography
  • Regional comparison
  • qPCR reagent market in Americas
  • qPCR reagent market in EMEA
  • qPCR reagent market in APAC
  • Market opportunity

PART 08: DECISION FRAMEWORK

PART 09: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 10: MARKET TRENDS

  • Increase in M&A and internal restructuring in life science industries
  • Increasing use of qPCR in food testing and GM crops risk assessment
  • Increased use of robotic qPCR to reduce human errors
  • Increasing point-of-care testing (POCT) qPCR units

PART 11: VENDOR LANDSCAPE

  • Competitive scenario
  • Investment opportunity

PART 12: KEY VENDOR ANALYSIS

  • Agilent Technologies
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche
  • Thermo Fisher Scientific
  • Other prominent vendors

PART 13: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Global qPCR reagent market 2016-2021 ($ millions)
  • Exhibit 02: Five forces analysis
  • Exhibit 03: Global qPCR reagent market by end-users 2016 (% share)
  • Exhibit 04: Global qPCR reagent market by end-users 2021 (% share)
  • Exhibit 05: Global qPCR reagent market 2016-2021 (% share)
  • Exhibit 06: Global qPCR reagent market by hospitals and diagnostic centers 2016-2021 ($ millions)
  • Exhibit 07: Global qPCR reagent market by pharmaceutical and biotechnological companies 2016-2021 ($ millions)
  • Exhibit 08: Global qPCR reagent market by others 2016-2021 ($ millions)
  • Exhibit 09: Global qPCR reagent market by product 2016 (% share)
  • Exhibit 10: Global qPCR reagent market by product 2016-2021 ($ millions)
  • Exhibit 11: Global dye-based qPCR reagent market 2016-2021 ($ millions)
  • Exhibit 12: Global probe-based qPCR reagent market 2016-2021 ($ millions)
  • Exhibit 13: Global qPCR reagent market by geography 2016-2021 (% share)
  • Exhibit 14: Regional comparison
  • Exhibit 15: qPCR reagent market in Americas 2016-2021 ($ millions)
  • Exhibit 16: qPCR reagent market in Americas: Year-on-year growth 2017-2021 (% share)
  • Exhibit 17: Top 3 countries in Americas
  • Exhibit 18: qPCR market in EMEA 2016-2021 ($ millions)
  • Exhibit 19: qPCR reagent market in EMEA: Year-on-year growth 2017-2021 (% share)
  • Exhibit 20: Top 3 countries in EMEA
  • Exhibit 21: qPCR reagent market in APAC 2016-2021 ($ millions)
  • Exhibit 22: qPCR reagent market in APAC: Year-on-year growth 2017-2021 (% share)
  • Exhibit 23: Top 3 countries in APAC
  • Exhibit 24: Factors attributing to vendor capability
  • Exhibit 25: Investment opportunity mapping
  • Exhibit 26: Agilent Technologies: Profile
  • Exhibit 27: Agilent Technologies: Strength assessment
  • Exhibit 28: Agilent Technologies: Strategy assessment
  • Exhibit 29: Agilent Technologies: Opportunity assessment
  • Exhibit 30: Bio-Rad Laboratories: Profile
  • Exhibit 31: Bio-Rad Laboratories: Strength assessment
  • Exhibit 32: Bio-Rad Laboratories: Strategy assessment
  • Exhibit 33: Bio-Rad Laboratories: Opportunity assessment
  • Exhibit 34: F. Hoffmann-La Roche: Profile
  • Exhibit 35: F. Hoffmann-La Roche: Strength assessment
  • Exhibit 36: F. Hoffmann-La Roche: Strategy assessment
  • Exhibit 37: F. Hoffmann-La Roche: Opportunity assessment
  • Exhibit 38: Thermo Fisher Scientific: Profile
  • Exhibit 39: Thermo Fisher Scientific: Strength assessment
  • Exhibit 40: Thermo Fisher Scientific: Strategy assessment
  • Exhibit 41: Thermo Fisher Scientific: Opportunity assessment
Back to Top